Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pennel in Chronic Liver Disease
NCT02347319Phase 4Completed
- Sponsor
- PharmaKing
- Start
- Apr 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of biphenyl dimethyl dicarboxylate + garlic oil in chronic liver disease (CLD) (3 arms), sponsored by PharmaKing. Primary endpoint: Normalized rate in serum Alanine Aminotransferase at 12 weeks. Started Apr 2012; status: completed.
02
Drugs
biphenyl dimethyl dicarboxylate + garlic oil
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on NCT02347319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347319.